MK-0159
MK-0159 is a potent, orally bioavailable small molecule inhibitor of CD38, developed for research into cardiac ischemia-reperfusion injury (IRI) . It demonstrates cardioprotective effects by mitigating myocardial damage, making it a valuable tool for in vivo and in vitro studies of cardiovascular disease and CD38-related pathways.
Product Specifications
CAS Number
2641484-61-7
Product Name Alternative
CD38
Field of Research
Immunology & Inflammation
Purity
98.05% (May vary between batches)
Solubility
DMSO:80 mg/mL (199.75 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.24 mM)
Smiles
COCCO[C@H]1CC[C@@H] (CC1) NC (=O) c1cc (nc2[nH]ccc12) -c1cncs1
Molecular Formula
C20H24N4O3S
Molecular Weight
400.495
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV781717 1.0 µg DNA
RPS2P20 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details